Le pityriasis rubra pilaire traité avec l’ixékizumab - Un essai pilote ouvert
Dans ce Medfyle
Commentaire de l'expert par Peter Lio, MD, FAAD
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AAD Virtual Meeting Experience and presented by:
Teri M. Greiling, MD, PhD
Dept. of Dermatology, Oregon Health and Science University, Portland, OR, USA
The content is produced by Infomedica, the official reporting partner of ADA 2020 Virtual Meeting. The summary text was drafted by Synthesis Editorial Ltd, and reviewed by Martina Lambertini, MD, an independent external expert, and approved by Hassan Galadari, MD, FAAD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Peter Lio, MD, FAAD
Northwestern University Feinberg School of Medicine, Chicago, IL
Medical Dermatology Associates of Chicago, Chicago, IL
About the Expert
Peter Lio, MD, FAAD
Northwestern University Feinberg School of Medicine, Chicago, IL
Medical Dermatology Associates of Chicago, Chicago, IL
Peter Lio, MD is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He currently serves as a board member and scientific advisory committee member for the National Eczema Association. He is a member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group and a founding faculty member of the Integrative Dermatology Certificate Program. He has over 150 publications and 2 textbooks.
References
1. Feldmeyer L, Mylonas A, Demaria O, et al. Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. JAMA Dermatol 2017;153(4):304–8.
